Mettler-Toledo International (NYSE:MTD) issued an update on its fourth quarter 2021 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $10.000-$10.050 for the period, compared to the Thomson Reuters consensus estimate of $9.990. The company issued revenue guidance of $1.01 billion-$1.01 billion, compared to the consensus revenue estimate of $1.01 billion.Mettler-Toledo International also updated its FY 2021 guidance to $33.350-$33.400 EPS.
Shares of NYSE MTD traded down $5.94 during mid-day trading on Thursday, reaching $1,518.25. The company’s stock had a trading volume of 91,360 shares, compared to its average volume of 104,432. The stock has a 50-day moving average of $1,471.51 and a two-hundred day moving average of $1,441.99. The stock has a market capitalization of $34.90 billion, a P/E ratio of 47.58, a P/E/G ratio of 2.60 and a beta of 1.03. The company has a debt-to-equity ratio of 10.30, a quick ratio of 0.86 and a current ratio of 1.24. Mettler-Toledo International has a 1-year low of $1,033.40 and a 1-year high of $1,626.62.
Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings data on Thursday, November 4th. The medical instruments supplier reported $8.72 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $8.28 by $0.44. Mettler-Toledo International had a net margin of 20.85% and a return on equity of 369.24%. The firm had revenue of $951.95 million during the quarter, compared to analysts’ expectations of $931.63 million. During the same period last year, the business earned $7.02 earnings per share. Mettler-Toledo International’s revenue was up 17.9% compared to the same quarter last year. Analysts predict that Mettler-Toledo International will post 33.42 EPS for the current fiscal year.
In other news, Director Olivier A. Filliol sold 6,537 shares of Mettler-Toledo International stock in a transaction on Tuesday, November 16th. The shares were sold at an average price of $1,538.49, for a total value of $10,057,109.13. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Gerry Keller sold 259 shares of Mettler-Toledo International stock in a transaction on Monday, November 15th. The shares were sold at an average price of $1,545.08, for a total transaction of $400,175.72. The disclosure for this sale can be found here. Insiders sold a total of 15,896 shares of company stock worth $24,532,645 over the last ninety days. Corporate insiders own 3.00% of the company’s stock.
A hedge fund recently raised its stake in Mettler-Toledo International stock. Morgan Stanley boosted its position in Mettler-Toledo International Inc. (NYSE:MTD) by 9.3% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 64,742 shares of the medical instruments supplier’s stock after purchasing an additional 5,515 shares during the quarter. Morgan Stanley owned about 0.28% of Mettler-Toledo International worth $89,690,000 as of its most recent filing with the Securities and Exchange Commission. Institutional investors own 92.27% of the company’s stock.
About Mettler-Toledo International
Mettler-Toledo International, Inc is a supplier of precision instruments and services. The firm manufactures weighing instruments for use in laboratory, industrial, packaging, logistics, and food retailing applications. It also manufactures several related analytical instruments and provides automated chemistry solutions used in drug and chemical compound discovery and development; and also, metal detection and other end-of-line inspection systems used in production and packaging and provides solutions for use in certain process analytics applications.
Recommended Story: Are all No-Load Funds Equal?
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.